Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: April 17, 2026 at 2:14 AM UTC
| NCT Number | NCT06760637 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 1,020 participants |
| Active Locations | 172 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | March 2, 2026 (Mar 2, 2026) |
As of April 17, 2026: Clinical trial NCT06760637 is currently recruiting participants. This clinical trial study for breast cancer is actively seeking new participants at 172 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06760637 is actively recruiting participants as of April 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 172 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06760637 was last updated Mar 2, 2026 (March 2, 2026). HelloStudys verifies this status automatically.